Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-017591

President and CEO acquired 20,000 shares (option exercise)

  • President and CEO gave 40,000 shares (gift)
  • President and CEO gave 40,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2022-03-08 Option exercise +20,000 $1.37 $27,400 46,970 D
Mack David Henry President and CEO 2021-03-09 Gift −40,000 147,915 I
Mack David Henry President and CEO 2021-03-09 Gift +40,000 80,000 I
Derivatives
Mack David Henry President and CEO 2022-03-08 Option exercise · Stock Option (right to buy) −20,000 220,644 D
Loading xslF345X03/doc4.xml…